In this perspective we report for the first time the concept of 'generic probiotics', as a practical solution to create access to probiotics for people in the developing world. Analogous to generic drugs, we reason that patent-expired probiotics are free to be used by others. In this context we discuss the importance of probiotic genome stability for linking health claims of the mother strain to the generic strain.
展开▼